Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.

Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of a...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Link, A, Bachmann, M
Formaat: Journal article
Taal:English
Gepubliceerd in: 2010

Gelijkaardige items